XML 12 R1.htm IDEA: XBRL DOCUMENT v3.19.2
Cover Page - shares
6 Months Ended
Jun. 30, 2019
Jul. 26, 2019
Cover page.    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2019  
Document Transition Report false  
Entity File Number 001-36297  
Entity Registrant Name Revance Therapeutics, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 77-0551645  
Entity Address, Address Line One 7555 Gateway Boulevard  
Entity Address, City or Town Newark  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94560  
City Area Code 510  
Local Phone Number 742-3400  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol RVNC  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   44,102,532
Entity Central Index Key 0001479290  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q2  
Amendment Flag false